Abstract:Recent advances in mass spectrometry-based chemical proteomics allow unbiased analysis of drug-target interactions under close to physiological conditions. In this study, we designed and synthesized two small molecule probes targeting fibroblast growth factor receptors (FGFRs) and applied them to evaluate the selectivity profiles of the FGFR inhibitors Dovitinib and Orantinib. Probe F2 was capable of enriching all members of the FGF receptor family as well as other kinases involved in cancer such as KDR, FLT4 and RET from lysates of cancer cells or human placenta tissue. In combination with the established Kinobeads (TM) approach, probe F2 facilitated the identification of the target spectrum of the two inhibitors confirming many of the previously identified (off-) targets such as AURKA, FLT4-VEGFR3, IKBKE and PDGFR beta. The newly synthesized probe enlarges the arsenal of chemical proteomic tools for the expression profiling of kinases and selectivity profiling of their inhibitors. It will also be useful in applications aiming at a better understanding of a drug's cellular mechanisms of action as well as highlighting potential beneficial or adverse side effects.Biological significance The synthesis of a new chemical affinity probe targeting FGF-receptors and many other kinases improved the general scope of drug selectivity profiling by chemical proteomics. The application of the developed chemical tool identified most of the known targets for the advanced clinical kinase inhibitors Dovitinib and Orantinib thus exemplify the practical utility of the developed probe and the results obtained shed further light on how these drugs exert their anti-cancer activity in cells. More generally speaking, the significance of the work is that the molecular tools presented here extend the application scope of kinobeads based kinase profiling to FGFR/VEGFR/PDGFR families, which thus may be generically employed for selectivity profiling of kinase inhibitors using chemical proteomics. The overall aim of such studies is to improve our understanding of how target as well as off-target profiles can be used to assess or predict the therapeutic efficacy of a drug. (C) 2013 Elsevier B.V. All rights reserved.

Proteomics Approach to Investigate Impact of Afgf Antagonist on Signal Transduction Pathway

Effects of a Synthetic Bfgf Antagonist Peptide on the Proteome of 3T3 Cells Stimulated with Bfgf

Ultrasensitive Fluorescent Probes Reveal an Adverse Action of Dipeptide Peptidase IV and Fibroblast Activation Protein During Proliferation of Cancer Cells.

A novel FGF2 antagonist peptide P8 with potent antiproliferation activity

Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells.

A Short Peptide Reverses the Aggressive Phenotype of Prostate Cancer Cells

Research on proteins associated, to differentiation of vascular adventitial myofibroblasts

Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation.

Antitumor Effect of a Short Peptide on P53-Null SKOV3 Ovarian Cancer Cells.

Identification of a Novel Afgf-Binding Peptide with Anti-Tumor Effect on Breast Cancer from Phage Display Library

Site-Directed Chemical Modification of Recombinant Human Afgf Mutant with Polyethylene Glycol

Comparative peptidome profiling reveals critical roles for peptides in the pathology of pancreatic cancer

Interference with connective tissue growth factor attenuated fibroblast-to-myofibroblast transition and pulmonary fibrosis

iTRAQ-Based Proteomic Analysis reveals possible target-related proteins and signal networks in human osteoblasts overexpressing FGFR2

Selection of Peptide Ligands Binding to Fibroblast Growth Factor Receptor 1.

A New Chemical Probe for Quantitative Proteomic Profiling of Fibroblast Growth Factor Receptor and Its Inhibitors.

Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity.

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 Using a Phage Display Peptide Library

Suppression of Tumor Growth and Metastasis by a VEGFR-1 Antagonizing Peptide Identified from a Phage Display Library.

Ligand based 3D-QSAR model, pharmacophore, molecular docking and ADME to identify potential fibroblast growth factor receptor 1 inhibitors

Phosphoproteomics Identifies Significant Biomarkers Associated with the Proliferation and Metastasis of Prostate Cancer